From: A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death
Group A
Group B
Subjects (n)
34
73
Families (n)
9
36
Women (n)
23 (67.6%)
38 (52.1%)
Patients with HCM (n)
21 (61.8%)
49 (67.1%)
Symptomatic carriers (n)
Average age at last visit (year)
47.28*
39.07